Trending Now
LATEST ARTICLES
The First Prescription Digital Therapeutic for Anxiety & Depression
Happify Health launched Ensemble, the first and only transdiagnostic prescription digital therapeutic for the treatment of patients who have Major Depressive Disorder (MDD) or...
The DeSci Revolution: When Medical Research No Longer Starts Inside Pharma
Medical innovation has traditionally followed a familiar path. Universities conduct research, pharmaceutical companies fund development, and healthcare professionals introduce new therapies to patients. However,...
The Capacity Crisis: Why Great Drugs Still Can’t Reach Patients
Launching an innovative therapy is only half the battle. Today, many pharmaceutical companies face a challenge that has little to do with clinical evidence...
Your Biggest Competitor Isn’t Another Drug—It’s Something Else Entirely
For decades, pharmaceutical marketers have focused on outperforming competing brands within the same drug class. However, healthcare has changed dramatically. Today, a medication may...
The In-Silico Sell: Can Pharma Convince Doctors to Trust AI-Generated Clinical Evidence?
As artificial intelligence reshapes clinical development, synthetic control arm marketing is becoming a new challenge for pharma brand teams. After all, how do you...
From Generic Giant to Global Innovator: How India Is Rebranding Pharma
India has long been known as the world's pharmacy because of its leadership in generic medicines. However, the industry is entering a new chapter....
The New Pricing Gatekeeper: Why HTA Is Becoming Pharma’s Biggest Marketing Challenge
Clinical success alone no longer guarantees commercial success. Health technology assessment marketing is becoming just as important as traditional physician marketing because reimbursement decisions...
The Peptide Gold Rush: Can Pharma Win Back Trust?
Peptide pharma marketing now sits at the center of a fast-growing trust challenge. Peptides have moved far beyond traditional medicine, thanks to wellness clinics,...
The Procedure Is the Product: Why Great Therapies Still Fail in the Real World
A breakthrough therapy can deliver strong clinical results and still struggle in the market. Why? Because success often depends on more than the molecule....
The Biometric Trigger: When Wearable Data Becomes a Marketing Signal
As wearable health technology becomes part of everyday life, pharmaceutical companies have an opportunity to rethink patient engagement. A wearable-integrated marketing strategy allows brands...
De-Prescribing Pharma Strategy: What Happens When Your Drug Makes the Cut List?
As healthcare shifts toward reducing unnecessary medications, pharmaceutical companies face a growing commercial challenge. A strong de-prescribing pharma strategy is becoming increasingly important as...
